FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

Guidance on Drug Importation

Federal Register notice: FDA makes available a final guidance entitled Importation of Certain FDA-Approved Human Prescription Drugs, Including Biologi...

Biologics

Inovio Covid-19 Vaccine Trial on Partial Hold

FDA places a partial clinical hold on an Inovio planned Phase 2/3 trial of its Covid-19 vaccine candidate INO-4800, including its Cellectra 2000 deliv...

Human Drugs

ANDA Amendments for Tentatively Approvals

FDA issues a guidance entitled ANDA Submissions Amendments and Requests for Final Approval to Tentatively Approved ANDAs.

Federal Register

Panel to Review Biogen Alzheimers BLA

Federal Register notice: FDA announces an 11/6 Advisory Committee meeting to review a Biogen BLA for aducanumab solution for treating Alzheimers disea...

Human Drugs

ANDA Guide on Failing to Respond to CRLs

FDA posts a draft guidance entitled Failure to Respond to an ANDA Complete Response Letter Within 1 the Regulatory Timeframe.

Federal Register

Federal Register Corrected on Kadom Pharma ANDAs

Federal Register notice: FDA corrects a notice that appeared in the 7/21 Federal Register announcing the withdrawal of approval for two ANDAs from Kad...

Federal Register

Final Rule on Drug Importation from Canada

Federal Register notice: FDA issues a final rule to allow importation of certain prescription drugs from Canada.

Human Drugs

Shionogi Expanded Use for Fetroja

FDA approves a Shionogi & Co. supplemental NDA for Fetroja (cefiderocol) for treating patients 18 years of age or older with hospital-acquired bacteri...

Human Drugs

ICH Draft Q&A Guide on DNA Reactive Impurities

FDA posts an International Council for Harmonization draft guidance entitled M7 Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharm...

FDA General

Since Our Last Issue ...

Industry news you may have missed since our last issue.